Cherng Peggy's Form 4 filing
NKGen Biotech, Inc. (NKGN) · filed Jun 2, 2025
- Accession no.
- 0001104659-25-055325
- Filed
- Jun 2, 2025, 12:11 PM ET
- Trade date
- May 27, 2025
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $2.50M. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cherng PeggyCIK 0001235503 | 10% Owner |
| CFIC-2015 NV Family Investments, LLCCIK 0002034776 | 10% Owner |
| Cherng Andrew Jin-ChanCIK 0002035448 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Common Stock | PPurchaseAcquired | +19,669,552 | $0.1271 | +$2,500,000.06 | 21,752,885 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Common Stock | PPurchaseAcquired | +39,339,103 | $0.1271 | +$4,999,999.99 | 39,339,103 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.